Use of AI in Clinical Research, Part 2 cover art

Use of AI in Clinical Research, Part 2

Use of AI in Clinical Research, Part 2

Listen for free

View show details

About this listen

In Part 2, Amir Kalali, MD, Independent Consultant, continues the discussion with Luca Pani, MD, focusing on how AI could fundamentally transform CNS drug development by enabling deeper biological insight, patient enrichment, and real-world outcome assessment, while emphasizing the cultural resistance, regulatory transparency, ethical trust, and leadership readiness required for responsible adoption.

No reviews yet